Imperva Stock Price, News & Analysis (NASDAQ:IMPV)

$47.10 -0.40 (-0.84 %)
(As of 02/23/2018 01:34 AM ET)
Previous Close$47.10
Today's Range$46.56 - $47.85
52-Week Range$37.17 - $52.40
Volume260,425 shs
Average Volume411,019 shs
Market Capitalization$1.60 billion
P/E Ratio70.30
Dividend YieldN/A
Beta1.79

About Imperva (NASDAQ:IMPV)

Imperva logoImperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry IT Services & Consulting
Sub-IndustrySystems Software
SectorTechnology
SymbolNASDAQ:IMPV
CUSIP45321L10
Phone+1-650-3459000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.56%
Quick Ratio2.55%

Price-To-Earnings

Trailing P/E Ratio70.2985074626866
Forward P/E Ratio-277.06
P/E GrowthN/A

Sales & Book Value

Annual Sales$321.72 million
Price / Sales4.98
Cash FlowN/A
Price / CashN/A
Book Value$7.06 per share
Price / Book6.67

Profitability

Trailing EPS$0.67
Net Income$22.87 million
Net Margins4.00%
Return on Equity4.76%
Return on Assets2.80%

Miscellaneous

Employees993
Outstanding Shares34,010,000

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva Inc (NASDAQ:IMPV) posted its quarterly earnings results on Thursday, February, 8th. The software maker reported $0.40 EPS for the quarter, beating the consensus estimate of $0.27 by $0.13. The software maker had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. Imperva had a net margin of 4.00% and a return on equity of 4.76%. The firm's revenue was up 16.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.32 earnings per share. View Imperva's Earnings History.

When will Imperva make its next earnings announcement?

Imperva is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Imperva.

Where is Imperva's stock going? Where will Imperva's stock price be in 2018?

15 brokers have issued twelve-month price objectives for Imperva's shares. Their predictions range from $39.00 to $61.00. On average, they anticipate Imperva's share price to reach $52.58 in the next year. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:

  • 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (2/16/2018)
  • 2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:

  • Allan Roger Tessler, Chairman of the Board (Age 81)
  • Christopher S. Hylen, President, Chief Executive Officer, Director (Age 56)
  • Mike Burns, Chief Financial Officer (Age 51)
  • Tram T. Phi, Senior Vice President, General Counsel, Corporate Secretary (Age 46)
  • Brett Hooper, Senior Vice President - People (Age 53)
  • Sunil D. Nagdev, Senior Vice President and General Manager, Incapsula, Professional and Customer Services (Age 53)
  • Terry Ray, Chief Technology Officer
  • David Nicholas Gee, Chief Marketing Officer (Age 48)
  • Amichai Shulman, Chief Scientific Officer (Age 47)
  • Michael D. Mooney, Chief Revenue Officer (Age 56)

Who owns Imperva stock?

Imperva's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.93%), Eagle Asset Management Inc. (3.90%), Clearbridge Investments LLC (3.75%), Carillon Tower Advisers Inc. (2.73%), Renaissance Technologies LLC (2.35%) and Millennium Management LLC (2.29%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.

Who sold Imperva stock? Who is selling Imperva stock?

Imperva's stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers Inc. PA, Caisse DE Depot ET Placement DU Quebec, 13D Management LLC, BlackRock Inc., TIAA CREF Investment Management LLC, Wells Fargo & Company MN, Allianz Asset Management GmbH and Cambridge Trust Co.. Company insiders that have sold Imperva company stock in the last year include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney and Sunil D Nagdev. View Insider Buying and Selling for Imperva.

Who bought Imperva stock? Who is buying Imperva stock?

Imperva's stock was bought by a variety of institutional investors in the last quarter, including Carillon Tower Advisers Inc., Renaissance Technologies LLC, Two Sigma Investments LP, Triarii Capital Management LP, Stanley Laman Group Ltd., Sei Investments Co., Deutsche Bank AG and Spark Investment Management LLC. View Insider Buying and Selling for Imperva.

How do I buy Imperva stock?

Shares of Imperva can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of Imperva stock can currently be purchased for approximately $47.10.

How big of a company is Imperva?

Imperva has a market capitalization of $1.60 billion and generates $321.72 million in revenue each year. The software maker earns $22.87 million in net income (profit) each year or $0.67 on an earnings per share basis. Imperva employs 993 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 Bridge Pkwy, REDWOOD CITY, CA 94065-1194, United States. The software maker can be reached via phone at +1-650-3459000 or via email at [email protected]


MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  566 (Vote Outperform)
Underperform Votes:  286 (Vote Underperform)
Total Votes:  852
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imperva (NASDAQ:IMPV) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.472.382.472.61
Ratings Breakdown: 2 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $52.58$51.33$51.91$50.66
Price Target Upside: 12.96% upside22.66% upside27.85% upside14.61% upside

Imperva (NASDAQ:IMPV) Consensus Price Target History

Price Target History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018Imperial CapitalBoost Price TargetOutperform -> Outperform$50.00 -> $55.00LowView Rating Details
2/9/2018Morgan StanleyBoost Price TargetUnderweight -> Underweight$37.00 -> $39.00HighView Rating Details
2/9/2018Evercore ISISet Price TargetBuy$56.00HighView Rating Details
2/9/2018Piper Jaffray CompaniesUpgradeNeutral -> Overweight$52.00HighView Rating Details
12/12/2017JPMorgan Chase & Co.DowngradeNeutral -> Underweight$45.00HighView Rating Details
11/9/2017OppenheimerReiterated RatingBuy$55.00N/AView Rating Details
11/9/2017Stifel NicolausReiterated RatingHold -> Hold$50.00 -> $47.00N/AView Rating Details
10/24/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/18/2017Royal Bank of CanadaReiterated RatingBuy$49.00N/AView Rating Details
10/10/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/9/2017Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
7/28/2017Monness Crespi & HardtBoost Price TargetBuy$55.00 -> $57.00HighView Rating Details
7/13/2017StephensReiterated RatingOverweight$53.00 -> $61.00LowView Rating Details
6/7/2017Susquehanna BancsharesInitiated CoveragePositive -> Positive$60.00LowView Rating Details
3/22/2017DA DavidsonReiterated RatingBuy$55.00LowView Rating Details
2/9/2017BTIG ResearchInitiated CoverageNeutralN/AView Rating Details
11/4/2016NomuraReiterated RatingHold$37.50N/AView Rating Details
11/4/2016Needham & Company LLCUpgradeHold -> Buy$64.00 -> $43.00N/AView Rating Details
11/4/2016MacquarieUpgradeNeutral -> OutperformN/AView Rating Details
10/22/2016Buckingham ResearchReiterated RatingNeutral$45.00N/AView Rating Details
10/15/2016Deutsche BankReiterated RatingHoldN/AView Rating Details
9/25/2016JMP SecuritiesReiterated RatingOutperform$50.00 -> $56.00N/AView Rating Details
9/13/2016WunderlichInitiated CoverageHold$50.00N/AView Rating Details
8/30/2016Pacific CrestDowngradeOverweight -> Sector Weight$47.00 -> $30.00N/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Imperva (NASDAQ:IMPV) Earnings History and Estimates Chart

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.13N/AView Earnings Details
2/8/2018Q4 2017$0.27$0.40$91.11 million$91.10 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.22$0.33$83.79 million$83.89 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.05($0.10)$74.30 million$74.44 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.62)($0.29)$68.16 million$72.31 millionViewListenView Earnings Details
2/8/2017Q416$0.03$0.32$70.22 million$78.40 millionViewListenView Earnings Details
11/3/2016Q316($0.16)$0.08$63.10 million$68.40 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.23)$66.06 million$57.87 millionViewListenView Earnings Details
5/5/2016Q116($0.28)($0.25)$59.65 million$59.80 millionViewListenView Earnings Details
2/3/2016Q415$0.15$0.20$68.11 million$72.70 millionViewListenView Earnings Details
10/29/2015Q3($0.05)$0.19$56.52 million$63.30 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.08)$48.40 million$53.50 millionViewListenView Earnings Details
5/7/2015Q115($0.38)($0.26)$40.50 million$44.80 millionViewListenView Earnings Details
2/5/2015Q414($0.04)($0.04)$49.80 million$51.40 millionViewListenView Earnings Details
10/30/2014Q314($0.63)($0.51)$40.00 million$42.70 millionViewListenView Earnings Details
7/31/2014Q2 2014($0.72)($0.59)$38.44 millionViewN/AView Earnings Details
5/1/2014Q114($0.41)($0.36)$31.73 million$31.50 millionViewListenView Earnings Details
2/6/2014Q413$0.11$0.12$41.63 million$42.70 millionViewListenView Earnings Details
11/5/2013Q313($0.05)($0.01)$34.43 million$35.10 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)($0.10)$31.38 million$31.30 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.10)($0.13)$27.49 million$28.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.02$0.06$29.91 million$31.80 millionViewListenView Earnings Details
11/1/2012Q3 2012($0.07)($0.08)ViewN/AView Earnings Details
8/9/2012($0.05)($0.02)ViewN/AView Earnings Details
5/3/2012($0.13)($0.12)ViewN/AView Earnings Details
2/9/2012($0.15)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Imperva (NASDAQ:IMPV) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.60)($0.60)($0.60)
Q2 20181($0.51)($0.51)($0.51)
Q3 20181($0.50)($0.50)($0.50)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Imperva (NASDAQ:IMPV)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 95.91%
Insider Trades by Quarter for Imperva (NASDAQ:IMPV)
Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Anthony J BettencourtDirectorSell66,037$46.98$3,102,418.2666,037View SEC Filing  
2/20/2018Michael D MooneyCROSell24,454$47.18$1,153,739.7224,454View SEC Filing  
8/24/2017Anthony J BettencourtDirectorSell99,598$43.59$4,341,476.8299,598View SEC Filing  
5/16/2017Sunil D NagdevSVPSell4,857$49.00$237,993.0016,290View SEC Filing  
5/15/2017Amichai ShulmanInsiderSell3,089$48.70$150,434.30100,151View SEC Filing  
5/10/2017Michael D MooneyCROSell52,356$47.51$2,487,433.5652,356View SEC Filing  
4/17/2017Amichai ShulmanInsiderSell3,085$41.97$129,477.4599,151View SEC Filing  
3/15/2017Amichai ShulmanInsiderSell3,085$41.85$129,107.2599,151View SEC Filing  
2/28/2017Mark E KraynakSVPSell45,314$41.63$1,886,421.8210,064View SEC Filing  
2/21/2017Anthony J BettencourtChairmanSell84,863$45.55$3,865,509.6584,863View SEC Filing  
2/21/2017Terrence J SchmidCFOSell4,500$45.53$204,885.00432View SEC Filing  
2/16/2017Mark E KraynakSVPSell1,731$46.10$79,799.103,858View SEC Filing  
2/15/2017Amichai ShulmanInsiderSell3,085$45.91$141,632.3595,713View SEC Filing  
1/17/2017Amichai ShulmanCTOSell3,085$40.60$125,251.00View SEC Filing  
12/21/2016Amichai ShulmanInsiderSell3,085$40.00$123,400.0091,830View SEC Filing  
11/16/2016Mark E KraynakSVPSell3,332$40.16$133,813.12448View SEC Filing  
11/15/2016Amichai ShulmanInsiderSell3,085$40.10$123,708.5092,000View SEC Filing  
10/17/2016Amichai ShulmanInsiderSell3,085$48.57$149,838.4591,062View SEC Filing  
10/3/2016Amichai ShulmanInsiderSell938$53.27$49,967.2695,085View SEC Filing  
9/23/2016Amichai ShulmanInsiderSell937$51.00$47,787.0095,084View SEC Filing  
9/23/2016Mark E. KraynakSVPSell5,582$51.00$284,682.00View SEC Filing  
9/15/2016Amichai ShulmanInsiderSell3,085$44.30$136,665.5094,147View SEC Filing  
8/16/2016Mark E KraynakSVPSell2,614$47.73$124,766.223,552View SEC Filing  
8/15/2016Amichai ShulmanInsiderSell3,085$46.87$144,593.9594,317View SEC Filing  
7/27/2016Amichai ShulmanInsiderSell3,085$46.28$142,773.8093,380View SEC Filing  
7/26/2016Mark E KraynakSVPSell2,967$46.15$136,927.052,968View SEC Filing  
6/23/2016Shlomo KramerMajor ShareholderSell75,000$45.12$3,384,000.001,304,521View SEC Filing  
6/20/2016Shlomo KramerMajor ShareholderSell75,000$40.24$3,018,000.001,304,521View SEC Filing  
5/31/2016Terrence J SchmidCFOSell5,000$37.66$188,300.00335View SEC Filing  
5/25/2016Anthony J BettencourtCEOSell50,000$36.15$1,807,500.0052,938View SEC Filing  
5/19/2016Shlomo KramerMajor ShareholderSell50,000$34.20$1,710,000.001,304,521View SEC Filing  
5/17/2016Shlomo KramerMajor ShareholderSell75,000$33.95$2,546,250.001,304,521View SEC Filing  
5/16/2016Terrence J SchmidCFOSell7,000$33.99$237,930.008,053View SEC Filing  
5/12/2016Shlomo KramerMajor ShareholderSell75,000$34.16$2,562,000.001,304,521View SEC Filing  
3/31/2016Mark E. KraynakSVPSell2,758$50.00$137,900.00View SEC Filing  
3/1/2016Amichai ShulmanCTOSell3,000$45.25$135,750.0089,527View SEC Filing  
2/24/2016Terrence J SchmidCFOSell6,500$41.82$271,830.007,468View SEC Filing  
2/17/2016Mark E KraynakSVPSell2,758$40.04$110,430.322,758View SEC Filing  
2/8/2016Albert A PimentelDirectorBuy5,000$38.93$194,650.004,475View SEC Filing  
2/8/2016Amichai ShulmanCTOSell4,150$38.12$158,198.0082,590View SEC Filing  
2/1/2016Amichai ShulmanCTOSell3,000$50.49$151,470.0086,740View SEC Filing  
1/4/2016Amichai ShulmanCTOSell5,812$60.36$350,812.3286,740View SEC Filing  
12/1/2015Amichai ShulmanCTOSell3,000$74.22$222,660.0086,740View SEC Filing  
11/19/2015Mark E. KraynakinsiderSell10,000$75.00$750,000.00View SEC Filing  
11/19/2015Tram T. PhiVPSell1,244$73.26$91,135.445,975View SEC Filing  
11/16/2015Anthony J. BettencourtCEOSell50,000$69.33$3,466,500.008,489View SEC Filing  
11/16/2015Mark E. KraynakinsiderSell3,789$68.73$260,417.97View SEC Filing  
11/12/2015Shlomo KramerMajor ShareholderSell100,000$71.65$7,165,000.001,259,521View SEC Filing  
11/6/2015Shlomo KramerMajor ShareholderSell50,000$72.14$3,607,000.001,259,521View SEC Filing  
11/4/2015Shlomo KramerMajor ShareholderSell25,000$72.05$1,801,250.001,259,521View SEC Filing  
11/4/2015Terrence J. SchmidCFOSell938$71.14$66,729.32View SEC Filing  
11/3/2015Shlomo KramerMajor ShareholderSell25,000$72.55$1,813,750.001,259,521View SEC Filing  
10/1/2015Amichai ShulmanCTOSell2,813$65.00$182,845.0084,802View SEC Filing  
8/31/2015Terrence J. SchmidCFOSell1,595$61.56$98,188.20View SEC Filing  
8/17/2015Mark E KraynakInsiderSell1,520$71.42$108,558.40View SEC Filing  
7/23/2015Amichai ShulmanCTOSell9,000$70.00$630,000.00View SEC Filing  
5/11/2015Amichai ShulmanCTOSell10,313$51.09$526,891.17View SEC Filing  
5/11/2015Mark E KraynakInsiderSell4,000$55.00$220,000.00View SEC Filing  
4/20/2015Mark E KraynakInsiderSell3,000$47.53$142,590.00View SEC Filing  
1/20/2015Mark E KraynakInsiderSell3,000$44.60$133,800.00View SEC Filing  
1/8/2015Amichai ShulmanCTOSell1,875$50.00$93,750.00View SEC Filing  
12/16/2014Amichai ShulmanCTOSell9,492$50.00$474,600.00View SEC Filing  
12/15/2014Amichai ShulmanCTOSell11,133$50.00$556,650.00View SEC Filing  
12/1/2014Amichai ShulmanCTOSell5,000$42.44$212,200.00View SEC Filing  
11/28/2014Yaniv ShayaVPSell2,512$44.00$110,528.00View SEC Filing  
11/20/2014Mark E KraynakInsiderSell6,140$42.00$257,880.00View SEC Filing  
11/14/2014Yaniv ShayaVPSell20,938$44.52$932,159.76View SEC Filing  
11/13/2014Mark E KraynakInsiderSell2,000$45.00$90,000.00View SEC Filing  
11/11/2014Tram T PhiVPSell10,076$43.50$438,306.00View SEC Filing  
11/4/2014Terrence J SchmidCFOSell20,000$40.73$814,600.00View SEC Filing  
11/3/2014Amichai ShulmanCTOSell5,000$41.09$205,450.00View SEC Filing  
10/31/2014Amichai ShulmanCTOSell7,500$36.56$274,200.00View SEC Filing  
10/31/2014Mark E KraynakInsiderSell2,000$36.56$73,120.00View SEC Filing  
10/6/2014Amichai ShulmanCTOSell2,500$30.00$75,000.00View SEC Filing  
9/2/2014Amichai ShulmanCTOSell5,000$30.00$150,000.00View SEC Filing  
8/21/2014Terrence J SchmidCFOSell15,000$29.07$436,050.00View SEC Filing  
5/23/2014Ralph PisaniVPSell8,613$21.31$183,543.03View SEC Filing  
5/21/2014Terrence SchmidCFOSell15,000$21.26$318,900.002,853View SEC Filing  
4/7/2014Shlomo KramerCEOSell60,000$50.53$3,031,800.001,229,521View SEC Filing  
4/2/2014Shlomo KramerCEOSell40,000$55.67$2,226,800.001,229,521View SEC Filing  
1/8/2014Shlomo KramerCEOSell20,000$50.10$1,002,000.001,219,521View SEC Filing  
1/7/2014Shlomo KramerCEOSell40,000$49.99$1,999,600.001,219,521View SEC Filing  
1/3/2014Shlomo KramerCEOSell40,000$48.31$1,932,400.001,219,521View SEC Filing  
1/2/2014Amichai ShulmanCTOSell22,875$47.68$1,090,680.0010,000View SEC Filing  
12/17/2013Amichai ShulmanCTOSell10,090$45.00$454,050.0010,000View SEC Filing  
12/2/2013Amichai ShulmanCTOSell12,410$44.13$547,653.3010,000View SEC Filing  
11/26/2013Yaniv ShayaVPSell5,243$43.92$230,272.565,000View SEC Filing  
11/21/2013Jason ForgetSVPSell8,558$38.98$333,590.84View SEC Filing  
11/21/2013Terrence SchmidCFOSell11,100$40.26$446,886.00View SEC Filing  
11/21/2013Tram PhiVPSell6,646$39.50$262,517.00View SEC Filing  
11/19/2013Mark KraynakVPSell3,190$37.80$120,582.0015,000View SEC Filing  
8/29/2013Yaniv ShayaVPSell4,375$48.00$210,000.00View SEC Filing  
8/26/2013Jason ForgetSVPSell2,500$47.50$118,750.00View SEC Filing  
8/26/2013Yaniv ShayaVPSell5,000$47.71$238,550.00View SEC Filing  
8/23/2013Terrence SchmidCFOSell2,539$47.20$119,840.80View SEC Filing  
8/21/2013Jason ForgetSVPSell2,500$47.00$117,500.00View SEC Filing  
8/20/2013Terrence SchmidCFOSell10,461$47.03$491,980.83View SEC Filing  
8/16/2013Jason ForgetSVPSell2,062$47.00$96,914.00View SEC Filing  
8/14/2013Tram PhiVPSell5,000$46.00$230,000.00View SEC Filing  
8/13/2013Jason ForgetSVPSell2,000$45.01$90,020.00View SEC Filing  
8/13/2013Mark KraynakVPSell10,000$44.41$444,100.0015,000View SEC Filing  
8/5/2013Amichai ShulmanCTOSell1,086$52.58$57,101.88View SEC Filing  
8/2/2013Amichai ShulmanCTOSell46,140$51.87$2,393,281.80View SEC Filing  
7/3/2013Amichai ShulmanCTOSell3,222$45.21$145,666.62View SEC Filing  
7/1/2013Amichai ShulmanCTOSell16,778$44.94$754,003.32View SEC Filing  
6/3/2013Amichai ShulmanCTOSell20,000$39.49$789,800.00View SEC Filing  
5/30/2013Amichai ShulmanCTOSell10,000$39.93$399,300.00View SEC Filing  
5/30/2013Yaniv ShayaVPSell4,375$40.40$176,750.00View SEC Filing  
5/29/2013Amichai ShulmanCTOSell20,000$39.96$799,200.00View SEC Filing  
5/28/2013Tram T PhiVPSell5,000$40.25$201,250.00View SEC Filing  
5/24/2013Yaniv ShayaVPSell2,250$40.00$90,000.00View SEC Filing  
5/14/2013Yaniv ShayaVPSell10,000$39.00$390,000.00View SEC Filing  
5/13/2013Albert A PimentelDirectorSell10,000$37.93$379,300.00View SEC Filing  
5/13/2013Ralph PisaniVPSell5,000$38.46$192,300.00View SEC Filing  
5/13/2013Terrence J SchmidCFOSell13,000$37.75$490,750.00View SEC Filing  
5/8/2013Jason ForgetSVPSell4,063$37.31$151,590.53View SEC Filing  
3/26/2013Amichai ShulmanCTOSell20,000$38.30$766,000.00View SEC Filing  
2/26/2013Amichai ShulmanCTOSell20,000$36.05$721,000.00View SEC Filing  
12/28/2012Amichai ShulmanCTOSell10,000$31.01$310,100.00View SEC Filing  
12/27/2012Amichai ShulmanCTOSell20,000$30.98$619,600.00View SEC Filing  
12/5/2012Michael BoodaeiDirectorSell30,000$31.48$944,400.00View SEC Filing  
11/27/2012Amichai ShulmanCTOSell20,000$29.06$581,200.00View SEC Filing  
11/7/2012James R TolonenDirectorBuy5,000$31.17$155,850.00View SEC Filing  
11/1/2012Amichai ShulmanCTOSell20,000$31.71$634,200.00View SEC Filing  
10/4/2012Michael BoodaeiDirectorSell30,000$34.03$1,020,900.00View SEC Filing  
9/5/2012Michael BoodaeiDirectorSell20,000$30.35$607,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Imperva (NASDAQ IMPV) News Headlines

Source:
DateHeadline
Imperva Inc (IMPV) CRO Sells $1,153,739.72 in StockImperva Inc (IMPV) CRO Sells $1,153,739.72 in Stock
www.americanbankingnews.com - February 22 at 6:32 PM
Imperva Inc (IMPV) Director Anthony J. Bettencourt Sells 66,037 SharesImperva Inc (IMPV) Director Anthony J. Bettencourt Sells 66,037 Shares
www.americanbankingnews.com - February 22 at 6:14 PM
Imperva Announces Transition of Its Chairman of the BoardImperva Announces Transition of Its Chairman of the Board
finance.yahoo.com - February 21 at 4:55 PM
Imperva (IMPV) Upgraded to Hold by ValuEngineImperva (IMPV) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - February 17 at 6:34 PM
Imperva (IMPV) Upgraded to "Strong-Buy" by Zacks Investment ResearchImperva (IMPV) Upgraded to "Strong-Buy" by Zacks Investment Research
www.americanbankingnews.com - February 17 at 6:00 PM
BRIEF-Elliott Reports Combined Economic Exposure Of About 6 Pct In ImpervaBRIEF-Elliott Reports Combined Economic Exposure Of About 6 Pct In Imperva
www.reuters.com - February 15 at 8:31 AM
Imperva Target of Unusually High Options Trading (IMPV)Imperva Target of Unusually High Options Trading (IMPV)
www.americanbankingnews.com - February 15 at 6:38 AM
Traders Purchase High Volume of Call Options on Imperva (IMPV)Traders Purchase High Volume of Call Options on Imperva (IMPV)
www.americanbankingnews.com - February 14 at 8:44 PM
Imperva Protects NetRefer Website and Customers From CyberattacksImperva Protects NetRefer Website and Customers From Cyberattacks
finance.yahoo.com - February 13 at 9:29 AM
Imperva (IMPV) Upgraded to "Overweight" by Piper Jaffray CompaniesImperva (IMPV) Upgraded to "Overweight" by Piper Jaffray Companies
www.americanbankingnews.com - February 10 at 10:22 PM
Evercore ISI Analysts Give Imperva (IMPV) a $56.00 Price TargetEvercore ISI Analysts Give Imperva (IMPV) a $56.00 Price Target
www.americanbankingnews.com - February 10 at 4:44 PM
Imperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial CapitalImperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial Capital
www.americanbankingnews.com - February 9 at 10:36 PM
Imperva (IMPV) Given New $39.00 Price Target at Morgan StanleyImperva (IMPV) Given New $39.00 Price Target at Morgan Stanley
www.americanbankingnews.com - February 9 at 6:42 PM
Imperva beats 4Q profit forecastsImperva beats 4Q profit forecasts
finance.yahoo.com - February 9 at 9:26 AM
Imperva (IMPV) Posts Quarterly  Earnings Results, Beats Expectations By $0.13 EPSImperva (IMPV) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS
www.americanbankingnews.com - February 8 at 9:28 PM
Investors Are Undervaluing Imperva Inc (NASDAQ:IMPV) By 28.08%, Here Is My Intrinsic Value CalculationInvestors Are Undervaluing Imperva Inc (NASDAQ:IMPV) By 28.08%, Here Is My Intrinsic Value Calculation
finance.yahoo.com - February 8 at 4:11 PM
Imperva, Inc. to Host Earnings CallImperva, Inc. to Host Earnings Call
finance.yahoo.com - February 8 at 4:11 PM
Zacks: Brokerages Anticipate Imperva Inc (IMPV) Will Post Quarterly Sales of $91.18 MillionZacks: Brokerages Anticipate Imperva Inc (IMPV) Will Post Quarterly Sales of $91.18 Million
www.americanbankingnews.com - February 8 at 9:08 AM
 Brokerages Anticipate Imperva Inc (IMPV) to Announce $0.27 Earnings Per Share Brokerages Anticipate Imperva Inc (IMPV) to Announce $0.27 Earnings Per Share
www.americanbankingnews.com - February 6 at 3:18 AM
Imperva Inc (IMPV) Receives Consensus Recommendation of "Hold" from AnalystsImperva Inc (IMPV) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 2 at 7:24 PM
Imperva: The Value-Destructive Effects Of Dilution - Seeking AlphaImperva: The Value-Destructive Effects Of Dilution - Seeking Alpha
seekingalpha.com - February 2 at 4:20 PM
Imperva (IMPV) Set to Announce Quarterly Earnings on ThursdayImperva (IMPV) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - February 1 at 1:56 AM
Survey Reveals Biggest API Security Concern is DDoS Threats and Bot AttacksSurvey Reveals Biggest API Security Concern is DDoS Threats and Bot Attacks
finance.yahoo.com - January 30 at 9:53 AM
Imperva Announces Organizational Changes to Sharpen Focus on Customers and Product Innovation, and Drive Operational EfficienciesImperva Announces Organizational Changes to Sharpen Focus on Customers and Product Innovation, and Drive Operational Efficiencies
finance.yahoo.com - January 22 at 5:51 PM
Imperva Inc (IMPV) Expected to Post Quarterly Sales of $91.18 MillionImperva Inc (IMPV) Expected to Post Quarterly Sales of $91.18 Million
www.americanbankingnews.com - January 22 at 10:36 AM
First Week of February 16th Options Trading For Imperva (IMPV)First Week of February 16th Options Trading For Imperva (IMPV)
www.nasdaq.com - January 17 at 3:32 PM
Imperva Appoints David Gee as Chief Marketing OfficerImperva Appoints David Gee as Chief Marketing Officer
finance.yahoo.com - January 11 at 8:35 AM
Imperva to Report Fourth Quarter and Full Year 2017 Financial ResultsImperva to Report Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - January 10 at 6:26 PM
Imperva Inc (IMPV) Receives Consensus Rating of "Hold" from AnalystsImperva Inc (IMPV) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - January 8 at 8:38 PM
BidaskClub Upgrades Imperva (IMPV) to "Hold"BidaskClub Upgrades Imperva (IMPV) to "Hold"
www.americanbankingnews.com - January 6 at 11:10 AM
 Analysts Expect Imperva Inc (IMPV) Will Announce Quarterly Sales of $91.18 Million Analysts Expect Imperva Inc (IMPV) Will Announce Quarterly Sales of $91.18 Million
www.americanbankingnews.com - January 5 at 12:24 PM
Technology Sector Update for 01/02/2018: MICT,CISQ,IMPV,BABA,GOOG,GOOGL - NasdaqTechnology Sector Update for 01/02/2018: MICT,CISQ,IMPV,BABA,GOOG,GOOGL - Nasdaq
www.nasdaq.com - January 2 at 8:51 PM
Imperva (IMPV) Announces Mike Burns as CFO - StreetInsider.com - StreetInsider.comImperva (IMPV) Announces Mike Burns as CFO - StreetInsider.com - StreetInsider.com
www.streetinsider.com - January 2 at 8:51 PM
BRIEF-Imperva Appoints Mike Burns As CFOBRIEF-Imperva Appoints Mike Burns As CFO
www.reuters.com - January 2 at 8:24 AM
A Peek Into The Markets: US Stock Futures Mixed On First Trading Day Of 2018 - BenzingaA Peek Into The Markets: US Stock Futures Mixed On First Trading Day Of 2018 - Benzinga
www.benzinga.com - January 2 at 8:24 AM
Imperva Appoints Mike Burns as CFOImperva Appoints Mike Burns as CFO
finance.yahoo.com - January 2 at 8:24 AM
Contrasting Imperva (IMPV) and Its CompetitorsContrasting Imperva (IMPV) and Its Competitors
www.americanbankingnews.com - December 29 at 9:30 AM
BidaskClub Lowers Imperva (IMPV) to SellBidaskClub Lowers Imperva (IMPV) to Sell
www.americanbankingnews.com - December 27 at 7:24 PM
Imperva Sees Unusually High Options Volume (IMPV)Imperva Sees Unusually High Options Volume (IMPV)
www.americanbankingnews.com - December 23 at 1:38 AM
Susquehanna Sees Increased Pace of M&A in Cybersecurity in 2018; Imperva (IMPV) Seen as Top Target - StreetInsider.comSusquehanna Sees Increased Pace of M&A in Cybersecurity in 2018; Imperva (IMPV) Seen as Top Target - StreetInsider.com
www.streetinsider.com - December 19 at 8:23 AM
Zacks: Brokerages Anticipate Imperva Inc (IMPV) Will Announce Quarterly Sales of $91.18 MillionZacks: Brokerages Anticipate Imperva Inc (IMPV) Will Announce Quarterly Sales of $91.18 Million
www.americanbankingnews.com - December 19 at 4:56 AM
Imperva (IMPV) Stock Rating Lowered by J P Morgan Chase & CoImperva (IMPV) Stock Rating Lowered by J P Morgan Chase & Co
www.americanbankingnews.com - December 18 at 12:20 AM
Imperva Inc (IMPV) Expected to Post Earnings of $0.27 Per ShareImperva Inc (IMPV) Expected to Post Earnings of $0.27 Per Share
www.americanbankingnews.com - December 17 at 5:32 PM
Imperva, Inc. (IMPV) Given Average Recommendation of "Hold" by AnalystsImperva, Inc. (IMPV) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - December 14 at 11:32 PM
Imperva (IMPV) versus Its Peers Financial SurveyImperva (IMPV) versus Its Peers Financial Survey
www.americanbankingnews.com - December 14 at 1:18 AM
Comparing Imperva (IMPV) & Its RivalsComparing Imperva (IMPV) & Its Rivals
www.americanbankingnews.com - December 14 at 1:18 AM
Critical Survey: Imperva (IMPV) versus Its PeersCritical Survey: Imperva (IMPV) versus Its Peers
www.americanbankingnews.com - December 12 at 9:34 PM
Imperva stock falls after JP Morgan downgrades to underweightImperva stock falls after JP Morgan downgrades to underweight
finance.yahoo.com - December 12 at 3:32 PM
Imperva Named a Leader in DDoS Mitigation Solutions | Business ... - Business Wire (press release)Imperva Named a Leader in DDoS Mitigation Solutions | Business ... - Business Wire (press release)
www.businesswire.com - December 11 at 6:36 PM
Imperva Named a Leader in DDoS Mitigation SolutionsImperva Named a Leader in DDoS Mitigation Solutions
finance.yahoo.com - December 11 at 8:23 AM

SEC Filings

Imperva (NASDAQ:IMPV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Imperva (NASDAQ IMPV) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.